1
0
M. COLZANI ET AL.
function in Zucker obese rats. J Cell Mol Med.
011;15:1339–1354.
17] Albrecht T, Schilperoort M, Zhang S, et al. Carnosine
attenuates the development of both type 2 diabetes
and diabetic nephropathy in BTBR ob/ob mice. Sci
Rep. 2017;7:44492.
18] Regazzoni L, de Courten B, Garzon D, et al. A carno-
sine intervention study in overweight human volun-
teers: bioavailability and reactive carbonyl species
sequestering effect. Sci Rep. 2016;6:27224.
19] Yeum K-J, Orioli M, Regazzoni L, et al. Profiling histi-
dine dipeptides in plasma and urine after ingesting
beef, chicken or chicken broth in humans. Amino
Acids. 2010;38:847–858.
20] Vistoli G, Colzani M, Mazzolari A, et al. Computational
approaches in the rational design of improved car-
bonyl quenchers: focus on histidine containing dipep-
tides. Future Med Chem. 2016;8:1721–1737.
21] Vistoli G, De Maddis D, Straniero V, et al. Exploring
the space of histidine containing dipeptides in search
of novel efficient RCS sequestering agents. Eur J Med
Chem. 2013;66:153–160.
[22] Hwang S, Lee Y-M, Aldini G, Yeum K-J. Targeting
reactive carbonyl species with natural sequestering
agents. Molecules. 2016;21:280.
23] Mano J, Nagata M, Okamura S, et al. Identification of
oxidatively modified proteins in salt-stressed
Arabidopsis: a carbonyl-targeted proteomics approach.
Plant Cell Physiol. 2014;55:1233–1244.
References
2
[
1] Vistoli G, De Maddis D, Cipak A, et al. Advanced glyco-
xidation and lipoxidation end products (AGEs and
ALEs): an overview of their mechanisms of formation.
Free Radic Res. 2013;47:3–27.
[
[
[
[
[
[
2] Sousa BC, Pitt AR, Spickett CM. Chemistry and analysis
of HNE and other prominent carbonyl-containing lipid
oxidation compounds. Free Radic Biol Med. 2017;111:
294–308.
[
3] Mano J, Biswas MS. Analysis of reactive carbonyl spe-
cies generated under oxidative stress. Methods Mol
Biol. 2018;1743:117–124.
[
4] Aldini G, Dalle-Donne I, Facino RM, et al. Intervention
strategies to inhibit protein carbonylation by lipoxida-
tion-derived reactive carbonyls. Med Res Rev.
2007;27:817–868.
[
[
5] Dalle-Donne I, Aldini G, Carini M, et al. Protein carbon-
ylation, cellular dysfunction, and disease progression.
J Cell Mol Med. 2006;10:389–406.
6] Poli G, Schaur RJ, Siems WG, Leonarduzzi G. 4-hydrox-
ynonenal: a membrane lipid oxidation product of
medicinal interest. Med Res Rev. 2008;28:569–631.
7] Poli G, Schaur RJ. 4-hydroxynonenal in the pathome-
chanisms of oxidative stress. Tbmb. 2001;50:315–321.
8] Mol M, Regazzoni L, Altomare A, et al. Enzymatic and
non-enzymatic detoxification of 4-hydroxynonenal:
methodological aspects and biological consequences.
Free Radic Biol Med. 2017;111:328–344.
[
[
[
[
9] N ꢀe gre-Salvayre A, Garoby-Salom S, Swiader A, et al.
[24] Biswas MS, Mano J. Reactive carbonyl species
activate caspase-3-like protease to initiate pro-
grammed cell death in plants. Plant Cell Physiol.
Proatherogenic effects of 4-hydroxynonenal. Free
Radic Biol Med. 2017;111:127–139.
[
[
10] Xiao M, Zhong H, Xia L, et al. Pathophysiology of
mitochondrial lipid oxidation: role of 4-hydroxynone-
nal (4-HNE) and other bioactive lipids in mitochondria.
Free Radic Biol Med. 2017;111:316–327.
11] Aldini G, Vistoli G, Stefek M, et al. Molecular strategies
to prevent, inhibit, and degrade advanced glycoxida-
tion and advanced lipoxidation end products. Free
Radic Res. 2013;47:93–137.
2
016;57:1432–1442.
[25] Beretta G, Furlanetto S, Regazzoni L, et al.. Quenching
of alpha, beta-unsaturated aldehydes by green tea
polyphenols: HPLC-ESI-MS/MS studies.
Biomed Anal. 2008;448:606–611.
J
Pharm
[26] Yeh W-J, Hsia S-M, Lee W-H, Wu C-H. Polyphenols
with antiglycation activity and mechanisms of action:
a review of recent findings. J Food Drug Anal.
2017;25:84–92.
[27] Zhu Q, Zheng Z-P, Cheng K-W, et al. Natural polyphe-
nols as direct trapping agents of lipid peroxidation-
derived acrolein and 4-hydroxy-trans-2-nonenal. Chem
Res Toxicol. 2009;22:1721–1727.
[28] Colzani M, Criscuolo A, De Maddis D, et al. A novel
high resolution MS approach for the screening of 4-
hydroxy-trans-2-nonenal sequestering agents. J Pharm
Biomed Anal. 2014;91:108–118.
[
[
12] Davies SS, Zhang LS. Reactive carbonyl species
scavengers-novel therapeutic approaches for chronic
diseases. Curr Pharmacol Rep. 2017;3:51–67.
13] Colzani M, De Maddis D, Casali G, et al. Reactivity,
selectivity, and reaction mechanisms of aminoguani-
dine, hydralazine, pyridoxamine, and carnosine as
sequestering agents of reactive carbonyl species:
a
1
comparative study. ChemMedChem 2016;11:
778–1789.
[
[
[
14] Aldini G, Dalle-Donne I, Colombo R, et al.
Lipoxidation-derived reactive carbonyl species as
potential drug targets in preventing protein carbonyla-
tion and related cellular dysfunction. ChemMedChem
[29] Rees MS, van Kuijk FJGM, Siakotos AN, Mundy BP.
Improved synthesis of various isotope labeled
4-hydroxyalkenals and peroxidation intermediates.
Synth Commun. 1995;25:3225–3236.
[30] Aldini G, Granata P, Marinello C, et al. Effects of UVB
radiation on 4-hydroxy-2-trans-nonenal metabolism
and toxicity in human keratinocytes. Chem Res
Toxicol. 2007;20:416–423.
[31] Dasuri K, Ebenezer P, Fernandez-Kim SO, et al. Role of
physiological levels of 4-hydroxynonenal on adipocyte
biology: implications for obesity and metabolic syn-
drome. Free Radic Res. 2013;47:8–19.
2006;1:1045–1058.
15] Aldini G, Carini M, Yeum KJ, et al. Novel molecular
approaches for improving enzymatic and nonenzy-
matic detoxification of 4-hydroxynonenal: toward the
discovery of a novel class of bioactive compounds.
Free Radic Biol Med. 2014;69:145–156.
16] Aldini G, Orioli M, Rossoni G, et al. The carbonyl scav-
enger carnosine ameliorates dyslipidaemia and renal